Scarica l'app Stockscreener
1.56
7.14%
-0.12
Dopo l'orario di chiusura:
1.56
Lipocine Inc Borsa (LPCN) Ultime notizie
Press Releases about Lipocine Inc.Common Stock (Nasdaq:LPCN) - FinancialContent
Lipocine Inc. (LPCN) stock price, news, quote and history - Yahoo Finance Singapore
Here's Why You Should Add LPCN Stock to Your Portfolio Now - TradingView
Here's Why You Should Add LPCN Stock to Your Portfolio Now - Zacks Investment Research
Here's Why You Should Add LPCN Stock to Your Portfolio Now - TradingView
Lipocine LPCN Rallies As BLOOM Phase 3 Trial Kicks Off - StocksToTrade
Lipocine (LPCN) Advances BLOOM Trial As Traders Eye Cash Runway - Timothy Sykes
Lipocine Shares Surge 30% After Health Canada Clears Oral Testosterone Drug - BigGo Finance
LPCN Stock Jumps As BLOOM Phase 3 Trial Kicks Off - StocksToTrade
Lipocine Surges After Canada Approves TLANDO - Quiver Quantitative
Why Is Lipocine Stock Soaring Today?Lipocine (NASDAQ:LPCN) - Benzinga
Lipocine Health Canada Approval Clears TLANDO for Canadian Testosterone Replacement Market - Yahoo Finance
Lipocine stock surges 30% on Health Canada drug approval - Yahoo Finance
LPCN Stock Pops As BLOOM Phase 3 Trial Kicks Off - www.timothysykes.com
LPCN Stock Pops As BLOOM Phase 3 Trial Kicks Off - Timothy Sykes
Hecla Mining, XPO, Lipocine - TradingView
Lipocine stock surges 30% on Health Canada drug approval - Investing.com
LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today - Stocktwits
LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today - Yahoo Finance
LPCN Stock Jumps As BLOOM Phase 3 Trial Kicks Off - StocksToTrade
Health Canada approves Lipocine’s testosterone therapy drug By Investing.com - Investing.com India
Health Canada approves Lipocine's oral testosterone drug TLANDO - StreetInsider
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy - PR Newswire
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy - Nasdaq
Lipocine (LPCN) Jumps As BLOOM Phase 3 Trial Kicks Off - Timothy Sykes
Lipocine (LPCN) Jumps As BLOOM Phase 3 Trial Kicks Off - Timothy Sykes
LPCN Jumps As Lipocine Launches Phase 3 BLOOM Trial - StocksToTrade
Health Canada approves Tlando oral testosterone therapy from Lipocine - StreetInsider
Lipocine Inc. (LPCN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lipocine Inc. (LPCN) stock price, news, quote and history - Yahoo Finance UK
Form 4 Lipocine Inc For: 1 October By Investing.com - Investing.com Nigeria
Lipocine director John Higuchi buys $55,042 in company stock By Investing.com - Investing.com South Africa
Lipocine director John Higuchi buys $55,042 in company stock By Investing.com - Investing.com Nigeria
Lipocine director John Higuchi buys $55,042 in company stock - Investing.com
Lipocine director John Higuchi buys $27,131 in company stock - Investing.com
Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Lipocine stock price target maintained at $4 by H.C. Wainwright - Investing.com
Lipocine (NASDAQ: LPCN) shares slides from New York investor conference - Stock Titan
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression - PR Newswire
Lipocine launches BLOOM Phase 3 study of LPCN 1154 for PPD; plans ~120 patients, expects $1M/mo cash use - TradingView
Form 8K Lipocine Inc For: 11 September By Investing.com - Investing.com Australia
Form 8K Lipocine Inc For: 11 September By Investing.com - Investing.com Nigeria
Lipocine Cuts ATM Sales Agent Fee to Up to 3.0% - minichart.com.sg
Form 8K Lipocine Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K Lipocine Inc For: 11 September By Investing.com - Investing.com South Africa
Lipocine updates sales agent fee agreement with A.G.P./Alliance Global Partners - Investing.com India
Lipocine updates sales agent fee agreement with A.G.P./Alliance Global Partners - Investing.com Canada
Lipocine updates sales agent fee agreement with A.G.P./Alliance Global Partners - Investing.com
Lipocine Updates Sales Agreement Fee Structure with A.G.P. - TipRanks
Lipocine (LPCN) sets sales agent commissions at up to 3% - Stock Titan
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):